Physician profile
Jayme Trahan
NPI 1700072238
$67,531.09
in general payments reported to CMS, 2019-2025
17 companies · $3,784 in 2025
The $3,784 reported for 2025 was more than what 77% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $18K · 2021: $13K · 2022: $12K · 2023: $4,867 · 2024: $145 · 2025: $3,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $8,305 · Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $8,305.49 |
| Food and Beverage | $491.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Institute of Musculoskeletal Science and Education | $63,609.99 | 2019-2025 | Spira, Enza |
| Boston Scientific Corporation | $1,046.20 | 2019-2025 | Intracept |
| Si-Bone, INC. | $881.49 | 2019-2022 | |
| Stryker Corporation | $550.18 | 2019-2023 | Mako |
| Philadelphia Medical Management Company LLC | $306.64 | 2020-2021 | |
| Providence Medical Technology, INC. | $222.74 | 2019-2022 | |
| Depuy Synthes Sales INC. | $212.60 | 2019-2021 | |
| Orthofix Medical, INC. | $177.72 | 2019-2022 | |
| Relievant Medsystems, INC. | $117.80 | 2022-2023 | Intracept |
| Abbott Laboratories | $92.74 | 2019-2021 | |
| Camber Spine Technologies LLC | $92.38 | 2019 | |
| Osseus Fusion Systems, LLC | $86.41 | 2019 | |
| Globus Medical, INC. | $32.42 | 2021 | |
| Arteriocyte Medical Systems, INC. | $31.21 | 2019-2022 | |
| Spinal Elements, INC. | $28.93 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $22.49 | 2022 | |
| Medtronic USA, INC. | $19.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$700,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayme Trahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.